News Headlines Article

How just $150K could shape the future of Alzheimer’s drug development
San Francisco Business Times

In the grand scheme of drug development, $150,000 is a blip. After all, pushing a drug from lab bench to patient bedside can take a decade or longer and cost foundations, the National Institutes of Health and venture-backed companies upward of $1 billion. But when it comes to Alzheimer’s Disease — the age-related, memory-stealing illness affecting more than 5 million Americans and drawing in more baby boomers daily — relatively small amounts of cash can do big things.